Show simple item record

The East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

dc.contributor.authorKim, Hyun Kuk
dc.contributor.authorTantry, Udaya S.
dc.contributor.authorSmith, Sidney C.
dc.contributor.authorJeong, Myung Ho
dc.contributor.authorPark, Seung Jung
dc.contributor.authorKim, Moo Hyun
dc.contributor.authorLim, Do Sun
dc.contributor.authorShin, Eun Seok
dc.contributor.authorPark, Duk Woo
dc.contributor.authorHuo, Yong
dc.contributor.authorChen, Shao Liang
dc.contributor.authorBo, Zheng
dc.contributor.authorGoto, Shinya
dc.contributor.authorKimura, Takeshi
dc.contributor.authorYasuda, Satoshi
dc.contributor.authorChen, Wen Jone
dc.contributor.authorChan, Mark
dc.contributor.authorAradi, Daniel
dc.contributor.authorGeisler, Tobias
dc.contributor.authorGorog, Diana A.
dc.contributor.authorSibbing, Dirk
dc.contributor.authorLip, Gregory Y.H.
dc.contributor.authorAngiolillo, Dominick J.
dc.contributor.authorGurbel, Paul A.
dc.contributor.authorJeong, Young Hoon
dc.date.accessioned2021-12-07T11:50:01Z
dc.date.available2021-12-07T11:50:01Z
dc.date.issued2020-11-10
dc.identifier.citationKim , H K , Tantry , U S , Smith , S C , Jeong , M H , Park , S J , Kim , M H , Lim , D S , Shin , E S , Park , D W , Huo , Y , Chen , S L , Bo , Z , Goto , S , Kimura , T , Yasuda , S , Chen , W J , Chan , M , Aradi , D , Geisler , T , Gorog , D A , Sibbing , D , Lip , G Y H , Angiolillo , D J , Gurbel , P A & Jeong , Y H 2020 , ' The East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease ' , Thrombosis and haemostasis , vol. 121 , no. 04 , pp. 11 . https://doi.org/10.1055/s-0040-1718729
dc.identifier.issn0340-6245
dc.identifier.urihttp://hdl.handle.net/2299/25230
dc.description© 2020. Thieme. All rights reserved. Georg Thieme Verlag KG. This is the accepted manuscript version of an article which has been published in final form at https://doi.org/10.1055/s-0040-1718729.
dc.description.abstractEast Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y 12receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients.en
dc.format.extent422
dc.format.extent1794070
dc.language.isoeng
dc.relation.ispartofThrombosis and haemostasis
dc.subjectantiplatelet therapy
dc.subjectbleeding risk
dc.subjectdirect oral anticoagulants
dc.subjectischemic risk
dc.subjectrace
dc.subjectHematology
dc.titleThe East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Diseaseen
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.date.embargoedUntil2021-11-10
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85096095586&partnerID=8YFLogxK
rioxxterms.versionofrecord10.1055/s-0040-1718729
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail
Name:
Paper_3a.pdf
Size:
1.710Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record